Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Pharmacol Biochem Behav ; 74(3): 609-16, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12543226

ABSTRACT

Prior stress exposure is known to alter the activation response to a subsequent stressor. In the present study, we examined neurochemical, neuroendocrinological, and behavioral correlates of short-term adaptation to homotypic stressors administered 60 min apart. An initial electric footshock significantly induced extracellular levels of both serotonin (5-HT) and norepinephrine (NE) in the rat hippocampus (650% and 200% above baseline, respectively), as measured by in vivo microdialysis. A rapid habituation in this response was evident in the inability of a second footshock to evoke similar increases. In contrast, the hypothalamic-pituitary-adrenal (HPA) response was augmented further after the second shock session: plasma corticosterone (CORT) levels were 18.1, 316.5, and 441.6 mg/ml in nonstressed, one-footshock-, or two-footshock-treated rats, respectively. In a social interaction paradigm, rats subjected to a single footshock showed several fear- and anxiety-related behaviors such as increases in freezing and decreases in rearing and active approach for social interaction. Exposure to a second footshock completely blocked the freezing response and restored rearing behavior without affecting the disruption in social interactions. Taken together, these data raise the possibility that neurochemical and neuroendocrine adaptations to short-term homotypic stressors differentially contribute to expression of different fear and anxiety-like responses in the rat.


Subject(s)
Anxiety/metabolism , Corticosterone/blood , Habituation, Psychophysiologic/physiology , Hippocampus/metabolism , Norepinephrine/metabolism , Serotonin/metabolism , Animals , Male , Rats , Rats, Sprague-Dawley , Stress, Physiological/metabolism
2.
J Med Chem ; 44(8): 1231-48, 2001 Apr 12.
Article in English | MEDLINE | ID: mdl-11312923

ABSTRACT

3-Guanidinopropionic acid (1) has been demonstrated both to improve insulin sensitivity and to promote weight loss selectively from adipose tissue in animal models of non-insulin-dependent diabetes mellitus (NIDDM). However, 1 has also been shown to be a substrate for both the creatine transporter and creatine kinase, leading to marked accumulation in muscle tissue as the corresponding N-phosphate. The corresponding aminoguanidine analogue 2 was recently discovered to retain the antidiabetic activity of 1 while being markedly less susceptible to creatine-like metabolism, suggesting that it should have less potential to accumulate in muscle. Further structural modification of 2 was undertaken to investigate whether the antidiabetic potency could be augmented while maintaining resistance to creatine-like metabolism. Modifications such as alpha-alkylation, homologation, and bioisosteric replacement of the aminoguanidine all were detrimental to antidiabetic activity. However, the simple regioisomeric aminoguanidinoacetic acid 9 and diaminoguanidinoacetic acid analogue 7 were found to be equipotent to 2, leading eventually to the discovery of the significantly more potent diaminoguanidinoacetic acid regioisomers 52 and 53. Further attempts to modify the more active template represented by 52 led only to reductions in antidiabetic activity. Each of the new active analogues displayed the same resistance to creatine-like metabolism as 2. Further testing of 7, 9, and 53 in obese diabetic ob/ob mice confirmed that weight loss is induced selectively from adipose tissue, similar to the lead 1. Administration of 53 to insulin-resistant rhesus monkeys led to reductions in both fasting and post-prandial plasma glucose levels with concomitant reductions in plasma insulin levels, suggesting that the compound improved the action of endogenous insulin. Compounds 7 and 53 were selected for further preclinical development.


Subject(s)
Acetates/chemical synthesis , Guanidines/chemistry , Guanidines/chemical synthesis , Hypoglycemic Agents/chemical synthesis , Membrane Transport Proteins , Propionates/chemistry , Acetates/chemistry , Acetates/pharmacology , Animals , Blood Glucose/analysis , Carrier Proteins/metabolism , Cell Line , Creatine/chemistry , Creatine/metabolism , Creatine Kinase/chemistry , Guanidines/pharmacology , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/pharmacology , In Vitro Techniques , Insulin Resistance , Macaca mulatta , Mice , Mice, Obese , Muscle, Smooth/cytology , Muscle, Smooth/metabolism , Phosphorylation , Structure-Activity Relationship
3.
J Med Chem ; 42(4): 573-83, 1999 Feb 25.
Article in English | MEDLINE | ID: mdl-10052964

ABSTRACT

Self-organizing molecular field analysis (SOMFA) is a novel technique for three-dimensional quantitative structure-activity relations (3D-QSAR). It is simple and intuitive in concept and avoids the complex statistical tools and variable selection procedures favored by other methods. Our calculations show the method to be as predictive as the best 3D-QSAR methods available. Importantly, steric and electrostatic maps can be produced to aid the molecular design process by highlighting important molecular features. The simplicity of the technique leaves scope for further development, particularly with regard to handling molecular alignment and conformation selection. Here, the method has been used to predict the corticosteroid-binding globulin binding affinity of the "benchmark" steroids, expanded from the usual 31 compounds to 43 compounds. Test predictions have also been performed on a set of sulfonamide endothelin inhibitors.


Subject(s)
Drug Design , Models, Molecular , Endothelins/antagonists & inhibitors , Steroids/chemistry , Structure-Activity Relationship , Sulfonamides/chemistry , Transcortin/chemistry
7.
Diabetes ; 44(8): 984-91, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7622005

ABSTRACT

The role of insulin resistance in the impaired glucose-stimulated insulin release of Zucker fatty rats was investigated using the insulin-sensitizing thiazolidinedione drug pioglitazone. Fatty rats had fasting hyperinsulinemia yet a blunted secretory response to intravenous glucose compared with lean age-matched controls. Islets from fatty rats secreted less insulin (based on islet DNA) in response to high glucose than islets from lean rats but secreted normal amounts of insulin when tolbutamide or alpha-ketoisocaproic acid (alpha-KIC) was the stimulus. Administering pioglitazone for 9 days diminished basal hyperinsulinemia and increased the insulin response to high glucose by fatty rats but not by lean controls. Pioglitazone pretreatment augmented the secretory response by isolated islets to high glucose, alpha-KIC, and tolbutamide. Augmentation of islet insulin release was not associated with reduced plasma glucose concentration, suggesting that altered glycemia was not involved. Pancreas and islet insulin content was greater in fatty rats than in lean controls and was decreased by pioglitazone; hence, insulin stores and glucose-stimulated insulin release did not correlate. Pioglitazone treatment did not affect the rate of islet glucose usage or ATP/ADP in the presence of 2.75 or 16 mmol/l glucose. These data indicate that ameliorating insulin resistance reverses defective glucose-stimulated insulin release by Zucker fa/fa rats. After pioglitazone administration, insulin secretion may be augmented by increased generation of a metabolic coupling factor from glucose or at a later step in the secretory process that is common to both glucose and nonglucose secretagogues.


Subject(s)
Hypoglycemic Agents/pharmacology , Insulin Resistance , Insulin/metabolism , Islets of Langerhans/metabolism , Thiazoles/pharmacology , Thiazolidinediones , Aging/physiology , Amino Acids/blood , Animals , Blood Glucose/metabolism , Fatty Acids, Nonesterified/blood , Female , Glucose/pharmacology , Insulin Secretion , Islets of Langerhans/drug effects , Pioglitazone , Rats , Rats, Zucker , Reference Values , Tolbutamide/pharmacology
8.
J Pharmacol Exp Ther ; 266(3): 1454-62, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8371149

ABSTRACT

To evaluate the long-held concept that acidic guanidines lack glycemic effects, guanidinoalkanoic acids and the biguanide metformin (positive control) were administered to KKAy mice, a model of noninsulin-dependent diabetes. Two acidic guanidines, 3-guanidinopropionic acid (3-GPA) and guanidinoacetic acid, decreased the plasma glucose level; other compounds were ineffective. 3-GPA was more potent than even metformin. Insulin suppression tests in KKAy mice indicated that improved insulin sensitivity was the mode of action for 3-GPA. Glycemic effects in KKAy mice resulted from increased glucose disposal whereas gluconeogenesis, hepatic glycogen content and intestinal glucose absorption were unchanged. 3-GPA's glycemic effect was corroborated in two other models of noninsulin-dependent diabetes. In ob/ob mice, the compound reduced hyperglycemia, polyuria, glycosuria and hyperinsulinemia. In insulin-resistant rhesus monkeys, it increased the disappearance of i.v. glucose. The glycemic action of 3-GPA required the presence of some circulating insulin as well as hyperglycemia because the compound was ineffective in normoglycemic mice, insulinopenic Chinese hamsters and streptozotocin-diabetic rats. These data indicate that acidic guanidine derivatives can ameliorate hyperglycemia in animal models of noninsulin-dependent diabetes. Because acidic derivatives uniquely lack the propensity of guanidine compounds for inducing lactic acidosis, our finding suggests a new approach for developing improved antidiabetes compounds from this chemical class.


Subject(s)
Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/drug therapy , Glucose/pharmacokinetics , Guanidines/pharmacology , Hyperglycemia/drug therapy , Propionates/pharmacology , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Gluconeogenesis/drug effects , Glycogen/metabolism , Hyperglycemia/blood , Hyperglycemia/metabolism , Insulin/blood , Insulin/pharmacology , Insulin Resistance , Intestinal Absorption , Liver Glycogen/metabolism , Macaca mulatta , Male , Metformin/pharmacology , Mice , Mice, Inbred C57BL , Mice, Obese , Muscles/metabolism , Structure-Activity Relationship
9.
Injury ; 24(2): 79-82, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8505131

ABSTRACT

A retrospective review of 21 patients between 10 and 19 years after a soft tissue injury to the cervical spine was undertaken. The clinical data showed a persistence of symptoms in 18 (86 per cent) of patients without any deterioration in the clinical signs. The radiological assessment did not show any evidence of injury leading to, or correlating with, the development or progression of degenerative changes in the cervical spine.


Subject(s)
Accidents, Traffic , Neck Injuries , Neck Muscles/injuries , Sprains and Strains/complications , Acute Disease , Adult , Aged , Cervical Vertebrae/diagnostic imaging , Humans , Kyphosis/diagnostic imaging , Middle Aged , Pain/etiology , Radiography , Retrospective Studies , Spinal Osteophytosis/etiology , Sprains and Strains/diagnostic imaging , Time Factors
10.
Anat Rec ; 233(1): 53-60, 1992 May.
Article in English | MEDLINE | ID: mdl-1605378

ABSTRACT

The morphology of the extratesticular rete and ductuli efferentes was reexamined in serial cross sections collected from the entire mass of the efferent ductules and in longitudinal sections collected from the partially unraveled efferent ductules. The extratesticular rete forms a 3-4-mm-long sac-like dilatation, which, within the head of the epididymis, has a wide lumen (up to 4 mm) and gives off along its length numerous evaginations, which, in turn, make connections with the ductuli efferentes. The latter is a mass of 16-18 ductules lined by three types of nonciliated cells: type II cells are characterized by dense, periodic acid-Schiff (PAS)-positive granules; type III cells are characterized by empty-appearing, PAS-negative vacuoles; and type I cells lack both granules and vacuoles. The distribution of the three types of nonciliated cells varies along the length. Whereas only type I cells are present in the beginning portion of the efferent ductule, type II cells predominate in the middle portion and type III cells in the distal portion (near the epididymis). The transition from one cell type to the other type is gradual; thus there are short segments along the length that share characteristics first for type I and type II cells and then for type II and type III cells. These results demonstrate that different nonciliated cell types are not randomly distributed in the epithelium of the ductuli efferentes but, instead, gradually differentiate from type I to type II to type III cells along the length of each efferent ductule. Factors controlling this differentiation remain to be studied.


Subject(s)
Goats/anatomy & histology , Rete Testis/anatomy & histology , Vas Deferens/anatomy & histology , Animals , Male , Rete Testis/cytology , Vas Deferens/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...